Atorvastatin Calcium
Product Images NDC 33261-972

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 33261-972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atorvastatin Calcium 20mg Tab For Ohm 1)

Chemical structure of Atorvastatin Calcium, showing its molecular components including phenyl rings, fluorophenyl group, hydroxyl groups, calcium ion, and water molecules of hydration.*

FDA Label Image

Table 3 (Atorvastatin Calcium 20mg Tab For Ohm 2)

Table showing the effect of co-administered drugs on the pharmacokinetics of Atorvastatin, listing drug names, dosing regimens, atorvastatin dose, and changes in AUC and Cmax. It includes various drugs such as Cyclosporine, Tipranavir, Ritonavir, Clarithromycin, and others, with fold or percentage increases or decreases in pharmacokinetic parameters compared to atorvastatin alone.*

FDA Label Image

Table 4 (Atorvastatin Calcium 20mg Tab For Ohm 3)

A data table titled 'Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs' showing Atorvastatin dosing regimens, co-administered drugs with dosing amounts, and the corresponding changes in AUC and Cmax values. The table includes drugs like Antipyrine, Digoxin, oral contraceptives, Tipranavir/ritonavir, and Fosamprenavir with various dosing periods and their pharmacokinetic impact when used with Atorvastatin.*

FDA Label Image

Figure1 (Atorvastatin Calcium 20mg Tab For Ohm 4)

A line graph comparing cumulative incidence percentages over a period of 3.5 years between Atorvastatin and placebo groups. The graph shows Atorvastatin with a lower cumulative incidence than placebo, including a hazard ratio (HR) of 0.60 with a 95% confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure2 (Atorvastatin Calcium 20mg Tab For Ohm 5)

A line graph comparing the cumulative hazard percentage over time, showing Atorvastatin versus placebo. The x-axis represents time to the first primary endpoint through four years of follow-up in years, and the y-axis shows cumulative hazard percentage. The graph indicates a lower hazard for Atorvastatin compared to placebo, with a hazard ratio (HR) and p-value noted on the graph.*

FDA Label Image

Figure3 (Atorvastatin Calcium 20mg Tab For Ohm 6)

A line chart depicting the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) for Atorvastatin 10 mg and 80 mg. The x-axis shows time to first major cardiovascular endpoint in years, while the y-axis shows the percentage of subjects. The chart includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*

FDA Label Image

Image Label (Atorvastatin Calcium 20mg Tab For Ohm 7)

Atorvastatin Calcium 20 mg tablet label from Aidarex Pharmaceuticals LLC. The label indicates 30 film-coated white oval tablets, generic for Lipitor, with active ingredients Atorvastatin 20 mg and Calcium. Manufacturer is OHM Laboratories Inc., North Brunswick, NJ. NDC 33261-0972-30 is shown.*

FDA Label Image

Image Label (Atorvastatin Calcium 20mg Tab For Ohm 8)

Packaging label for Atorvastatin Calcium 20 mg tablets by Aidarex Pharmaceuticals LLC. The label states the product contains 90 film-coated tablets, with each white oval tablet containing 20 mg of atorvastatin calcium. It is labeled as generic for Lipitor and includes the NDC 33261-0972-90. Manufacturer is OHM Laboratories Inc., North Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.